The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Open accessAbstract
The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identified and reviewed the available evidence for the ten most important areas of controversy in advanced prostate cancer (APC) management. The successful registration of several drugs for castration-resistant prostate cancer and the recent studies of chemo-hormonal therapy in men with castration-naïve prostate cancer have led to considerable uncertainty as to the best treatment choices, sequence of treatment options and appropriate patient selection. Management recommendations based on expert opinion, and not based on a critical review of the available evidence, are presented. The various recommendations carried differing degrees of support, as reflected in the wording of the article text and in the detailed voting results recorded in supplementary Material, available at Annals of Oncology online. Detailed decisions on treatment as always will involve consideration of disease extent and location, prior treatments, host factors, patient preferences as well as logistical and economic constraints. Inclusion of men with APC in clinical trials should be encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572 · cited 1×
“Sipuleucel-T was tested predominantly ( 85%) in chemotherapy-naïve men with CRPC [2].”
Self-citationIncreased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Scher, H. I., Fizazi, K., Saad, F., Taplin, M.-E., Sternberg, C. N., Miller, K., de Wit, R., Mulders, P., Chi, K. N., Shore, N. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207506 · Cited by 4,586
Self-citationThe Delphi Technique: Making Sense of Consensus
Hsu, C.-C., & Sandford, B. A. (2007) · University of Massachusetts Amherst · doi:10.7275/pdz9-th90 · Cited by 4,500 · cited 1×
“Questions and options for answers were later revised and sent a second time to all panel members, including all inputs received shown in an anonymised fashion, so all the panellists could see every comment from their colleagues [11].”
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
Self-citationGoldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Albain, K. S., André, F., Bergh, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt303 · Cited by 3,746
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Self-citationde Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J.-P., Kocak, I., Gravis, G., Bodrogi, I., Mackenzie, M. J., Shen, L., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61389-x · Cited by 3,318
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405095 · Cited by 3,028
Self-citationAbiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209096 · Cited by 2,796
Self-citationScher, H. I., Halabi, S., Tannock, I., Morris, M., Sternberg, C. N., Carducci, M. A., Eisenberger, M. A., Higano, C., Bubley, G. J., Dreicer, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4487 · Cited by 2,241
Self-citationFizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Self-citationSaad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger, M. A., Blumenstein, B. A., Crawford, E. D., Miller, G., McLeod, D. G., Loehrer, P. J., Wilding, G., Sears, K., Culkin, D. J., Thompson, I. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391504 · Cited by 859
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02163-2 · Cited by 819
Smith, M. R., Saad, F., Coleman, R., Shore, N., Fizazi, K., Tombal, B., Miller, K., Sieber, P., Karsh, L., Damião, R., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61226-9 · Cited by 797
Self-citationGravis, G., Fizazi, K., Joly, F., Oudard, S., Priou, F., Esterni, B., Latorzeff, I., Delva, R., Krakowski, I., Laguerre, B., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70560-0 · Cited by 744
Self-citationKlotz, L. H., BOCCON-GIBOD, L., Shore, N. D., Andreou, C., Persson, B., Cantor, P., Jensen, J.-K., Olesen, T. K., & Schröder, F. H. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08183.x · Cited by 666
Self-citationSmall, E. J., Halabi, S., Dawson, N. A., Stadler, W. M., Rini, B. I., Picus, J., Gable, P., Torti, F. M., Kaplan, E., & Vogelzang, N. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.037 · Cited by 504
Self-citationSartor, O., Coleman, R., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70183-4 · Cited by 497
Self-citationJames, N. D., Spears, M. R., Clarke, N. W., Dearnaley, D. P., De Bono, J. S., Gale, J., Hetherington, J., Hoskin, P. J., Jones, R. J., Laing, R., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.09.032 · Cited by 425
Self-citationAggressive Variants of Castration-Resistant Prostate Cancer
Beltran, H., Tomlins, S., Aparicio, A., Arora, V., Rickman, D., Ayala, G., Huang, J., True, L., Gleave, M. E., Soule, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3309 · Cited by 420
Self-citationAkakura, K., Bruchovsky, N., Goldenberg, S. L., Rennie, P. S., Buckley, A. R., & Sullivan, L. D. (1993) · Cancer · doi:10.1002/1097-0142(19930501)71:9<2782::aid-cncr2820710916>3.0.co;2-z · Cited by 373
Tolis, G., Ackman, D., Stellos, A., Mehta, A., Labrie, F., Fazekas, A. T., Comaru-Schally, A. M., & Schally, A. V. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1658 · Cited by 368
Shen, G., Deng, H., Hu, S., & Jia, Z. (2014) · Skeletal Radiology · doi:10.1007/s00256-014-1903-9 · Cited by 363
Loriot, Y., Bianchini, D., Ileana, E., Sandhu, S., Patrikidou, A., Pezaro, C., Albiges, L., Attard, G., Fizazi, K., De Bono, J. S., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt136 · Cited by 357
Self-citationOst, P., Bossi, A., Decaestecker, K., De Meerleer, G., Giannarini, G., Karnes, R. J., Roach, M., & Briganti, A. (2015) · European Urology · doi:10.1016/j.eururo.2014.09.004 · Cited by 349
Huggins, C., & Scott, W. W. (1945) · Annals of Surgery · doi:10.1097/00000658-194512260-00012 · Cited by 346
Noonan, K. L., North, S., Bitting, R. L., Armstrong, A. J., Ellard, S. L., & Chi, K. N. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt138 · Cited by 343
Lecouvet, F. E., El Mouedden, J., Collette, L., Coche, E., Danse, E., Jamar, F., Machiels, J.-P., Vande Berg, B., Omoumi, P., & Tombal, B. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.020 · Cited by 303
Self-citationLogothetis, C. J., Basch, E., Molina, A., Fizazi, K., North, S. A., Chi, K. N., Jones, R. J., Goodman, O. B., Mainwaring, P. N., Sternberg, C. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70473-4 · Cited by 280
Self-citationEvangelista, L., Zattoni, F., Guttilla, A., Saladini, G., Zattoni, F., Colletti, P. M., & Rubello, D. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182867f3c · Cited by 278
Labrie, F., Dupont, A., Bèlanger, A., Cusan, L., Lacourcière, Y., Monfette, G., LaBerge, J., Emond, J., Fazekas, A. T. A., Raynaud, J., et al. (1982) · PubMed · Cited by 276
Ferraldeschi, R., Nava Rodrigues, D., Riisnaes, R., Miranda, S., Figueiredo, I., Rescigno, P., Ravi, P., Pezaro, C., Omlin, A., Lorente, D., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.027 · Cited by 268
Self-citationSamson, D. J., Seidenfeld, J., Schmitt, B., Hasselblad, V., Albertsen, P. C., Bennett, C. L., Wilt, T. J., & Aronson, N. (2002) · Cancer · doi:10.1002/cncr.10647 · Cited by 259
Smith, M. R., Halabi, S., Ryan, C. J., Hussain, A., Vogelzang, N., Stadler, W., Hauke, R. J., Monk, J. P., Saylor, P., Bhoopalam, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.6500 · Cited by 251
Self-citationEfstathiou, E., Titus, M., Wen, S., Hoang, A., Karlou, M., Ashe, R., Tu, S. M., Aparicio, A., Troncoso, P., Mohler, J., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.05.005 · Cited by 248
Self-citationMezynski, J., Pezaro, C., Bianchini, D., Zivi, A., Sandhu, S., Thompson, E., Hunt, J., Sheridan, E., Baikady, B., Sarvadikar, A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds119 · Cited by 246
Self-citationNelson, J. B., Love, W., Chin, J. L., Saad, F., Schulman, C. C., Sleep, D. J., Qian, J., Steinberg, J., Carducci, M., & for the Atrasentan Phase 3 Study Group (2008) · Cancer · doi:10.1002/cncr.23864 · Cited by 245
Smith, M. R., Saad, F., Oudard, S., Shore, N., Fizazi, K., Sieber, P., Tombal, B., Damiao, R., Marx, G., Miller, K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.6716 · Cited by 241
Self-citationRyan, C. J., Shah, S., Efstathiou, E., Smith, M. R., Taplin, M.-E., Bubley, G. J., Logothetis, C. J., Kheoh, T., Kilian, C., Haqq, C. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0815 · Cited by 219
Self-citationFizazi, K., Scher, H. I., Miller, K., Basch, E., Sternberg, C. N., Cella, D., Forer, D., Hirmand, M., & de Bono, J. S. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70303-1 · Cited by 208
Self-citationVisceral Disease in Castration-resistant Prostate Cancer
Pezaro, C. J., Omlin, A., Lorente, D., Nava Rodrigues, D., Ferraldeschi, R., Bianchini, D., Mukherji, D., Riisnaes, R., Altavilla, A., Crespo, M., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.10.055 · Cited by 207
Self-citationCaubet, J.-F., Tosteson, T. D., Dong, E. W., Naylon, E. M., Whiting, G. W., Ernstoff, M. S., & Ross, S. D. (1997) · Urology · doi:10.1016/s0090-4295(96)00325-1 · Cited by 204
Sweeney, C., Chen, Y.-H., Carducci, M. A., Liu, G., Jarrard, D. F., Eisenberger, M. A., Wong, Y.-N., Hahn, N. M., Kohli, M., Vogelzang, N. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.lba2 · Cited by 202
Self-citationMetastatic Carcinoma of the Prostate: Identifying Prognostic Groups Using Recursive Partitioning
GLASS, T. R., TANGEN, C. M., CRAWFORD, E. D., & THOMPSON, I. (2003) · Journal of Urology · doi:10.1016/s0022-5347(05)64059-1 · Cited by 193
Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
Efstathiou, E., Titus, M., Tsavachidou, D., Tzelepi, V., Wen, S., Hoang, A., Molina, A., Chieffo, N., Smith, L. A., Karlou, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7675 · Cited by 189
Self-citationKAISARY, A. V., TYRRELL, C. J., PEELING, W. B., & GRIFFITHS, K. (1991) · British Journal of Urology · doi:10.1111/j.1464-410x.1991.tb15195.x · Cited by 181
Armstrong, A. J., Eisenberger, M. A., Halabi, S., Oudard, S., Nanus, D. M., Petrylak, D. P., Sartor, A. O., & Scher, H. I. (2012) · European Urology · doi:10.1016/j.eururo.2011.11.009 · Cited by 181
Self-citationVogelzang, N. J., Chodak, G. W., Soloway, M. S., Block, N. L., Schellhammer, P. F., Smith, J. A., Caplan, R. J., & Kennealey, G. T. (1995) · Urology · doi:10.1016/s0090-4295(99)80197-6 · Cited by 169
Al Nakouzi, N., Le Moulec, S., Albigès, L., Wang, C., Beuzeboc, P., Gross-Goupil, M., de La Motte Rouge, T., Guillot, A., Gajda, D., Massard, C., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.04.015 · Cited by 164
Self-citationCrawford, E. D., TOMBAL, B. F., Miller, K., et al. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.083 · Cited by 154
Self-citationPezaro, C. J., Omlin, A. G., Altavilla, A., Lorente, D., Ferraldeschi, R., Bianchini, D., Dearnaley, D. P., Parker, C. C., Bono, J. S. D., & Attard, G. (2013) · European Urology · doi:10.1016/j.eururo.2013.11.044 · Cited by 153
Self-citationMorris, M. J., Molina, A., Small, E. J., Bono, J. S. D., Logothetis, C. J., Fizazi, K. S., SOUZA, P. D., Kantoff, P. W., Higano, C. S., Li, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3875 · Cited by 145
Self-citationBlackledge, M., Collins, D. J., Tunariu, N., Orton, M. R., Padhani, A. R., Leach, M. O., & Koh, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091779 · Cited by 131
Self-citationBrasso, K., Thomsen, F. B., Schrader, A. J., Schmid, S. C., Lorente, D., Retz, M. M., Merseburger, A. S., von Klot, C. A., Boegemann, M., & Bono, J. S. D. (2014) · European Urology · doi:10.1016/j.eururo.2014.07.028 · Cited by 121
James, N. D., Sydes, M. R., Mason, M. D., Clarke, N. W., Dearnaley, D. P., Spears, M. R., Millman, R., Parker, C. C., Ritchie, A. W. S., Russell, J. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.5001 · Cited by 121
Self-citationNiraula, S., Le, L. W., & Tannock, I. F. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5492 · Cited by 121
Self-citationTherapy monitoring of skeletal metastases with whole-body diffusion MRI
Padhani, A. R., Makris, A., Gall, P., Collins, D. J., Tunariu, N., & Bono, J. S. D. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24548 · Cited by 119
Self-citationChallenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer
Crawford, E. D., Stone, N. N., Yu, E. Y., Koo, P. J., Freedland, S. J., Slovin, S. F., Gomella, L. G., Berger, E. R., Keane, T. E., SIEBER, P. R., et al. (2014) · Urology · doi:10.1016/j.urology.2013.10.026 · Cited by 102
Self-citationSchweizer, M. T., Zhou, X. C., Wang, H., Yang, T.-A., Shaukat, F., Partin, A. W., Eisenberger, M. A., & Antonarakis, E. S. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt335 · Cited by 101
Suzman, D. L., Luber, B. S., Schweizer, M. T., Nadal, R., & Antonarakis, E. S. (2014) · The Prostate · doi:10.1002/pros.22844 · Cited by 94
Intermittent Androgen Suppression for Prostate Cancer: Rationale and Clinical Experience
Gleave, M. E., Bruchovsky, N., Goldenberg, S. L., & Rennie, P. S. (1998) · European Urology · doi:10.1159/000052297 · Cited by 90
Self-citationTOMBAL, B. F., Rezazadeh, A., Therasse, P., Cangh, P. J. V., Berg, B. V., & Lecouvet, F. E. (2005) · The Prostate · doi:10.1002/pros.20280 · Cited by 87
Self-citationCheng, H. H., Gulati, R., Azad, A., Nadal, R., Twardowski, P., Vaishampayan, U. N., Agarwal, N., Heath, E. I., Pal, S. K., Rehman, H.-T., et al. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2014.53 · Cited by 85
Andriole, G. L. (2012) · Yearbook of Urology · doi:10.1016/j.yuro.2012.06.017 · Cited by 72
Intermittent androgen suppression for prostate cancer: rationale and clinical experience
Gleave, M. E., Goldenberg, S. L., Bruchovsky, N., et al. (1998) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500260 · Cited by 70
Self-citationPSA Flare With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer
Burgio, S. L., Conteduca, V., Rudnas, B., Carrozza, F., Campadelli, E., Bianchi, E., Fabbri, P., Montanari, M., Carretta, E., Menna, C., et al. (2014) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2014.06.010 · Cited by 68
The postchemotherapy PSA surge syndrome
Thuret, R., Massard, C., Gross‐Goupil, M., Escudier, B. J., Palma, M. D., Bossi, A., de Crevoisier, R., Chauchereau, A., & Fizazi, K. S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn062 · Cited by 65
Self-citationSpritzer, C. E., Afonso, P. D., Vinson, E. N., Turnbull, J. D., Morris, K. K., Foye, A., Madden, J. F., Choudhury, K. R., Febbo, P. G., & George, D. J. (2013) · Radiology · doi:10.1148/radiol.13121782 · Cited by 64
Angelergues, A., Maillet, D., Fléchon, A., Özgüroğlu, M., Mercier, F., Guillot, A., Moulec, S. L., Gravis, G., Beuzeboc, P., Massard, C., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.03.015 · Cited by 58
Self-citationThe CT flare response of metastatic bone disease in prostate cancer
Messiou, C., Cook, G., Reid, A. H. M., Attard, G., Dearnaley, D. P., Bono, J. S. D., & de Souza, N. M. (2011) · Acta Radiologica · doi:10.1258/ar.2011.100342 · Cited by 58
Self-citationSella, A., Sella, T., Peer, A., Berger, R., Frank, S. J., Gez, E., Sharide, D., Hayat, H., Hanovich, E., Kovel, S., et al. (2014) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2014.06.007 · Cited by 40
Self-citationSuccessful whole-exome sequencing from a prostate cancer bone metastasis biopsy
Allen, E. M. V., Foye, A., Wagle, N., Kim, W., Carter, S. L., McKenna, A., Simko, J. P., Garraway, L. A., & Febbo, P. G. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2013.37 · Cited by 36
Body weight, serum cholesterol, and stage of primary breast cancer
Howson, C. P., Kinne, D. W., & Wynder, E. L. (1986) · Cancer · doi:10.1002/1097-0142(19861201)58:11<2546::aid-cncr2820581131>3.0.co;2-n · Cited by 36
Akaza, H., Procopio, G., Pripatnanont, C., Facchini, G., Fava, S., Wheatley, D. A., Leung, K. C., Butt, M., Silva, A., Castillo, L., et al. (2018) · Journal of Global Oncology · doi:10.1200/jgo.18.00009 · Cited by 34
Self-citationPetrelli, F., Coinu, A., Borgonovo, K., Cabiddu, M., Ghilardi, M., Lonati, V., & Barni, S. (2014) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2014.10.006 · Cited by 24
Aggarwal, R. R., Halabi, S., Kelly, W. K., George, D. J., Mahoney, J. F., Millard, F. E., Stadler, W. M., Morris, M. J., Kantoff, P. W., Monk, J. P., et al. (2013) · Cancer · doi:10.1002/cncr.28285 · Cited by 18
Self-citation
Cited by
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Fizazi, K., Tran, N., Fein, L., Matsubara, N., Rodriguez-Antolin, A., Alekseev, B. Y., Özgüroğlu, M., Ye, D., Feyerabend, S., Protheroe, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704174 · Cited by 2,308
Self-citationCornford, P., Bellmunt, J., Bolla, M., Briers, E., De Santis, M., Gross, T., Henry, A. M., Joniau, S., Lam, T. B., Mason, M. D., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.002 · Cited by 1,438
Self-citationClinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.046 · Cited by 1,079
Self-citationBeer, T. M., Kwon, E. D., Drake, C. G., Fizazi, K., Logothetis, C., Gravis, G., Ganju, V., Polikoff, J., Saad, F., Humanski, P., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1584 · Cited by 765
Self-citation
Metadata
- Authors
- Gillessen, S., Omlin, A., Attard, G., de Bono, J. S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., Soule, H. R., Akaza, H., Beer, T. M., Beltran, H., Chinnaiyan, A. M., Daugaard, G., Davis, I. D., De Santis, M., Drake, C. G., Eeles, R. A., Fanti, S., Gleave, M. E., Heidenreich, A., Hussain, M., James, N. D., Lecouvet, F. E., Logothetis, C. J., Mastris, K., Nilsson, S., Oh, W. K., Olmos, D., Padhani, A. R., Parker, C., Rubin, M. A., Schalken, J. A., Scher, H. I., Sella, A., Shore, N. D., Small, E. J., Sternberg, C. N., Suzuki, H., Sweeney, C. J., Tannock, I. F., & Tombal, B.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 26
- Issue
- 8
- Pages
- 1589-1604
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2117460748
- Cited by
- 322
- References
- 79
- FWCI
- 42.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.